Drug ID: | NPD6674 |
Drug Name: | VM-301 |
Molecular Formula: | C26H38O6 |
Canonical SMILES: | COc1c(O[C@@H]2OC[C@H]([C@@H]([C@H]2O)O)O)c2[C@@H](C)CC[C@H]3c2c(c1C)[C@@H](C=C(C)C)C[C@@H]3C |
Standard InCHI: | InChI=1S/C26H38O6/c1-12(2)9-16-10-14(4)17-8-7-13(3)19-21(17)20(16)15(5)24(30-6)25(19)32-26-23(29)22(28)18(27)11-31-26/h9,13-14,16-18,22-23,26-29H,7-8,10-11H2,1-6H3/t13-,14-,16-,17+,18+,22-,23+,26-/m0/s1 |
Standard InCHIKey: | URDVEWJGRGQYQT-RSORJSBDSA-N |
Max Developmental Stage: | Discontinued |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB012676 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 446.27 |
ALogP | 1.2217 |
MLogP | 3.66 |
XLogP | 5.238 |
HDA | 4 |
HBD | 3 |
Rotatable Bonds | 13 |
TPSA | 88.38 |
RO5 Violation | 1 |